tiprankstipranks
OncoSec Medical (ONCSQ)
OTHER OTC:ONCSQ
US Market

OncoSec Medical (ONCSQ) Income Statement

Compare
486 Followers

OncoSec Medical Income Statement

Last quarter (Q2 2023), OncoSec Medical's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, OncoSec Medical's net income was $-6.86M. See OncoSec Medical’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Sep 22Sep 21Sep 20Sep 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -1.07M$ -1.08M$ -990.29K$ -243.71K
Operating Expenses
$ 37.01M$ 48.38M$ 43.41M$ 30.42M
Depreciation and Amortization
$ 1.07M$ 1.08M$ 990.29K$ 243.71K
EBITDA
$ -36.43M$ -47.30M$ -42.23M$ -29.73M
Operating Income
$ -37.01M$ -48.38M$ -43.41M$ -30.42M
Other Income/Expenses
$ -501.72K$ 800.14K$ 283.07K$ 141.92K
Pretax Income
$ -37.51M$ -47.58M$ -43.13M$ -30.27M
Net Income
$ -34.18M$ -45.17M$ -42.25M$ -30.28M
Per Share Metrics
$ ―$ ―$ ―$ ―
Basic EPS
$ -19.13$ -30.20$ -56.22$ -94.43
Diluted EPS
$ -19.13$ -30.20$ -56.22$ -94.43
Weighted Average Shares Outstanding
1.79M 1.50M 751.57K 320.60K
Weighted Average Shares Outstanding (Diluted)
1.79M 1.50M 751.57K 320.60K
Currency in USD

OncoSec Medical Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis